RecruitingPhase 2NCT07008456

A Study to Investigate the Efficacy and Safety of Two Different Doses of Twice Daily Distal Jejunal-release Dextrose Beads Formulations Combined With a Gel Composition Compared to Placebos in Obese Subjects With Weight Related Comorbidities

A Phase II Study to Investigate the Efficacy and Safety of Two Different Doses of Twice Daily Distal Jejunal-release Dextrose Beads Formulations (APHD 012 and APHD 002) Combined With a Gel Composition, Compared With Two Different Doses of the Placebo Beads Formulations (APHP 012 and APHP 002) Combined With a Gel Composition in Obese Subjects With Weight Related Comorbidities


Sponsor

Aphaia Pharma US LLC

Enrollment

102 participants

Start Date

Sep 12, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this randomized, double-blind, placebo-controlled, phase IIa study is to demonstrate superiority on body weight reduction of two different doses of twice daily distal jejunal-release dextrose beads formulations (APHD 012 and APHD 002) combined with a gel composition, compared with two different doses of the placebo beads formulations (APHP 012 and APHD 002) combined with a gel composition in obese subjects with weight related comorbidities.


Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called APHD-002, a drug called APHD-012, and others for people with obese patients (bmi ≥ 30 kg/m²) and obese with comorbidities. The study is currently recruiting participants at 6 locations. People eligible for this study include aged 18 Years to 75 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGAPHD-012

12 g dextrose beads

DRUGAPHD-002

2 g dextrose beads

DRUGAPHP-012

12 g placebo beads

DRUGAPHP-002

2 g placebo beads


Locations(6)

LTD "Israeli-Georgian Medical Research Clinic Healthycore"

Tbilisi, K'alak'i T'bilisi, Georgia

LTD "New Hospitals"

Tbilisi, K'alak'i T'bilisi, Georgia

LTD "Acad. G. Chapidze Emergency Cardiology Center"

Tbilisi, K'alak'i T'bilisi, Georgia

LTD "Diacor"

Tbilisi, K'alak'i T'bilisi, Georgia

NNLE "Jo Ann University Hospital"

Tbilisi, K'alak'i T'bilisi, Georgia

LTD The First Medical Center

Tbilisi, K'alak'i T'bilisi, Georgia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07008456


Related Trials